Non-coding RNAs

…histone and RNA modifications, non-coding RNAs, heterochromatin, nucleosome structure and nuclear architecture. Researchers will connect transcriptional control with developmental processes and disease mechanisms, using single-cell genomics and advanced microscopy alongside molecular approaches. The programme also considers how ageing, environmental exposures and lifestyle influence epigenetic states. The meeting brings together researchers working across

MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression at a post-transcriptional level. Their tissue-specific expression patterns, high stability in blood, and ability to cross the blood-brain barrier make them promising biomarker candidates for diagnosing central nervous system (CNS) disorders. However, further characterization of miRNA biomarkers is needed to identify key factors for diagnosing CNS disorders. In this study, we aimed to detect and characterize a differentially expressed miRNA as a biomarker for Major Depressive Disorder (MDD). We performed RNA sequencing o

…could induce dysregulation of non-coding RNAs (ncRNAs), similar to epileptogenic brain insults and seizures observed in-vivo.Rat primary cortical cultures were exposed to 11 chemoconvulsants (4-aminopyridine, amoxapine, bicuculline, chlorpromazine, donepezil, kainic acid, pentylenetetrazol, picrotoxin, pilocarpine HCl, SNC80, strychnine HCl) for 24 h, followed by extraction of RNA for sequencing. Salmon tool quantified ncRNAs. DESeq2 analyzed differential expressions. qPCR validations for samples exposed to amoxapine, ch

…system are functionally integrated by non-coding RNAs (ncRNAs), which have recently emerged as key regulators of cellular activity throughout the phases of memory and in the adaptive immune system. Given

microRNAs (miRNAs) are small non-coding RNAs (ncRNAs) of ~22 nucleotides that regulate gene expression in all biological processes in health and disease, including nerve injury-induced neuronal regeneration and neuropathic pain. Although miRNAs have been under investigation for their potential application as biomarkers or even in novel therapeutic approaches, the signaling pathways involved in their regulation as well as their biological role remains elusive. Mice were subjected to the spared nerve injury model for neuropathic pain and paired-miRNA::mRNA sequencing was performed on dorsal root

The inhibitory actions of the heterogeneous collection of GABAergic interneurons tremendously influence cortical information processing, which is reflected by diseases like autism, epilepsy and schizophrenia that involve defects in cortical inhibition. Apart from the regulation of physiological processes like synaptic transmission, proper interneuron function also relies on their correct development. Hence, decrypting regulatory networks that direct proper cortical interneuron development as well as adult functionality is of great interest, as this helps to identify critical events implicated

The establishment of effective therapies for neurodegenerative and neuropsychiatric diseases is still challenging and one of the reasons is that especially for age-associated neurodegenerative diseases pathology accumulates long before there are any clinical signs of disease. Thus, patients are often only diagnosed at an already advanced state of molecular pathology, when causative therapies fail. Thus, there is an urgent need for molecular biomarkers that could detect individuals at risk for developing a CNS disease and stratify patients. I will address epigenetic processes such as histone-mo

Developmental and epileptic encephalopathies (DEEs) are a broad spectrum of genetic epilepsies associated with impaired neurological development as a direct consequence of a genetic mutation, in addition to the effect of the frequent epileptic activity on brain. Compelling genetic studies indicate that heterozygous de novo mutations represent the most common underlying genetic mechanism, in accordance with the sporadic presentation of DEE. De novo mutations may exert a loss-of-function (LOF) on the protein by decrementing expression level and/or activity, leading to functional haploinsufficien